Home Healthcare Healthcare IT NGS Data Analysis Market

NGS Data Analysis Market Size, Share & Trends Analysis Report By Read Length (Short-read Sequencing, Long-read Sequencing, Very Long-read Sequencing), By Product (Services, NGS Commercial Software), By Workflow (NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Tertiary Data Analysis), By Mode (In-house Data Analysis, Outsourced Data Analysis), By End User (Academic Research, Clinical Research, Hospitals and Clinics, Pharma & Biotech Entities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. NGS Data Analysis Market, By Read Length 2022-2034 (USD MILLION/ Units)
    1. Short-read Sequencing
    2. Long-read Sequencing
    3. Very Long-read Sequencing
  2. NGS Data Analysis Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Services
    2. NGS Commercial Software
  3. NGS Data Analysis Market, By Workflow 2022-2034 (USD MILLION/ Units)
    1. NGS Primary Data Analysis
    2. NGS Secondary Data Analysis
    3. NGS Tertiary Data Analysis
  4. NGS Data Analysis Market, By Mode 2022-2034 (USD MILLION/ Units)
    1. In-house Data Analysis
    2. Outsourced Data Analysis
  5. NGS Data Analysis Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Academic Research
    2. Clinical Research
    3. Hospitals and Clinics
    4. Pharma & Biotech Entities
    5. Others
  6. Regional NGS Data Analysis Market
    1. North America
      1. North America NGS Data Analysis Market By Read Length 2022-2034 (USD MILLION/ Units)
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
      2. North America NGS Data Analysis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Services
        2. NGS Commercial Software
      3. North America NGS Data Analysis Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Primary Data Analysis
        2. NGS Secondary Data Analysis
        3. NGS Tertiary Data Analysis
      4. North America NGS Data Analysis Market By Mode 2022-2034 (USD MILLION/ Units)
        1. In-house Data Analysis
        2. Outsourced Data Analysis
      5. North America NGS Data Analysis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma & Biotech Entities
        5. Others
      6. U.S.
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      7. Canada
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
    2. Europe
      1. Europe NGS Data Analysis Market By Read Length 2022-2034 (USD MILLION/ Units)
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
      2. Europe NGS Data Analysis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Services
        2. NGS Commercial Software
      3. Europe NGS Data Analysis Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Primary Data Analysis
        2. NGS Secondary Data Analysis
        3. NGS Tertiary Data Analysis
      4. Europe NGS Data Analysis Market By Mode 2022-2034 (USD MILLION/ Units)
        1. In-house Data Analysis
        2. Outsourced Data Analysis
      5. Europe NGS Data Analysis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma & Biotech Entities
        5. Others
      6. U.K.
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      7. Germany
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      8. France
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      9. Spain
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      10. Italy
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      11. Russia
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      12. Nordic
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      13. Benelux
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      14. Rest of Europe
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
    3. APAC
      1. APAC NGS Data Analysis Market By Read Length 2022-2034 (USD MILLION/ Units)
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
      2. APAC NGS Data Analysis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Services
        2. NGS Commercial Software
      3. APAC NGS Data Analysis Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Primary Data Analysis
        2. NGS Secondary Data Analysis
        3. NGS Tertiary Data Analysis
      4. APAC NGS Data Analysis Market By Mode 2022-2034 (USD MILLION/ Units)
        1. In-house Data Analysis
        2. Outsourced Data Analysis
      5. APAC NGS Data Analysis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma & Biotech Entities
        5. Others
      6. China
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      7. Korea
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      8. Japan
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      9. India
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      10. Australia
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      11. Taiwan
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      12. South East Asia
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      13. Rest of Asia-Pacific
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
    4. Middle East and Africa
      1. Middle East and Africa NGS Data Analysis Market By Read Length 2022-2034 (USD MILLION/ Units)
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
      2. Middle East and Africa NGS Data Analysis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Services
        2. NGS Commercial Software
      3. Middle East and Africa NGS Data Analysis Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Primary Data Analysis
        2. NGS Secondary Data Analysis
        3. NGS Tertiary Data Analysis
      4. Middle East and Africa NGS Data Analysis Market By Mode 2022-2034 (USD MILLION/ Units)
        1. In-house Data Analysis
        2. Outsourced Data Analysis
      5. Middle East and Africa NGS Data Analysis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma & Biotech Entities
        5. Others
      6. UAE
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      7. Turkey
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      8. Saudi Arabia
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      9. South Africa
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      10. Egypt
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      11. Nigeria
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      12. Rest of MEA
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
    5. LATAM
      1. LATAM NGS Data Analysis Market By Read Length 2022-2034 (USD MILLION/ Units)
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
      2. LATAM NGS Data Analysis Market By Product 2022-2034 (USD MILLION/ Units)
        1. Services
        2. NGS Commercial Software
      3. LATAM NGS Data Analysis Market By Workflow 2022-2034 (USD MILLION/ Units)
        1. NGS Primary Data Analysis
        2. NGS Secondary Data Analysis
        3. NGS Tertiary Data Analysis
      4. LATAM NGS Data Analysis Market By Mode 2022-2034 (USD MILLION/ Units)
        1. In-house Data Analysis
        2. Outsourced Data Analysis
      5. LATAM NGS Data Analysis Market By End User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma & Biotech Entities
        5. Others
      6. Brazil
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      7. Mexico
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      8. Argentina
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      9. Chile
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      10. Colombia
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
      11. Rest of LATAM
        1. Short-read Sequencing
        2. Long-read Sequencing
        3. Very Long-read Sequencing
        4. Services
        5. NGS Commercial Software
        6. NGS Primary Data Analysis
        7. NGS Secondary Data Analysis
        8. NGS Tertiary Data Analysis
        9. In-house Data Analysis
        10. Outsourced Data Analysis
        11. Academic Research
        12. Clinical Research
        13. Hospitals and Clinics
        14. Pharma & Biotech Entities
        15. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.